 Clinical trial to target patients with Myelodysplastic Syndromes MDS and Chronic Myelomonocytic Leukemia CMML, both cancers that can progress into Acute Myeloid Leukemia AML Clinical trial to target patients with Myelodysplastic Syndromes MDS and Chronic Myelomonocytic Leukemia CMML, both cancers that can progress into Acute Myeloid Leukemia AML 